{
  "id": [
    "31999695"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "31999695"
  ],
  "pmcid": [
    "PMC6991954"
  ],
  "doi": [
    "10.1371/journal.pntd.0007860"
  ],
  "title": [
    "Reassessing therapeutic antibodies for neglected and tropical diseases."
  ],
  "authorString": [
    "Hooft van Huijsduijnen R, Kojima S, Carter D, Okabe H, Sato A, Akahata W, Wells TNC, Katsuno K."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Hooft van Huijsduijnen R"
          ],
          "firstName": [
            "Rob"
          ],
          "lastName": [
            "Hooft van Huijsduijnen"
          ],
          "initials": [
            "R"
          ],
          "authorId": [
            {
              "_": "0000-0002-2261-9424",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medicines for Malaria Venture, Geneva, Switzerland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kojima S"
          ],
          "firstName": [
            "Somei"
          ],
          "lastName": [
            "Kojima"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Chiba-Nishi General Hospital, Chiba, Japan."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Carter D"
          ],
          "firstName": [
            "Dee"
          ],
          "lastName": [
            "Carter"
          ],
          "initials": [
            "D"
          ],
          "authorId": [
            {
              "_": "0000-0002-4638-0059",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "School of Life and Environmental Sciences and The Marie Bashir Institute, University of Sydney, NSW, Australia."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Okabe H"
          ],
          "firstName": [
            "Hisafumi"
          ],
          "lastName": [
            "Okabe"
          ],
          "initials": [
            "H"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Chugai Pharmaceutical Co, Ltd., Tokyo, Japan."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Sato A"
          ],
          "firstName": [
            "Akihide"
          ],
          "lastName": [
            "Sato"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Chugai Pharmaceutical Co, Ltd., Tokyo, Japan."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Akahata W"
          ],
          "firstName": [
            "Wataru"
          ],
          "lastName": [
            "Akahata"
          ],
          "initials": [
            "W"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "VLP Therapeutics, Gaithersburg, Maryland, United States of America."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Wells TNC"
          ],
          "firstName": [
            "Timothy N C"
          ],
          "lastName": [
            "Wells"
          ],
          "initials": [
            "TNC"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medicines for Malaria Venture, Geneva, Switzerland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Katsuno K"
          ],
          "firstName": [
            "Kei"
          ],
          "lastName": [
            "Katsuno"
          ],
          "initials": [
            "K"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Global Health Innovative Technology Fund, Tokyo, Japan.",
                "London School of Hygiene and Tropical Medicine, London, United Kingdom.",
                "Nagasaki University School of Tropical Medicine and Global Health, Nagasaki, Japan."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-2261-9424",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-4638-0059",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics",
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "14"
      ],
      "journalIssueId": [
        "2896460"
      ],
      "dateOfPublication": [
        "2020 Jan"
      ],
      "monthOfPublication": [
        "1"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-01-01"
      ],
      "journal": [
        {
          "title": [
            "PLoS neglected tropical diseases"
          ],
          "ISOAbbreviation": [
            "PLoS Negl Trop Dis"
          ],
          "medlineAbbreviation": [
            "PLoS Negl Trop Dis"
          ],
          "NLMid": [
            "101291488"
          ],
          "ISSN": [
            "1935-2727"
          ],
          "ESSN": [
            "1935-2735"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "e0007860"
  ],
  "abstractText": [
    "In the past two decades there has been a significant expansion in the number of new therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of these new medicines has been driven primarily by new approaches in inflammatory diseases and oncology, especially in immuno-oncology. Other recent successes have included new antibodies for use in viral diseases, including HIV. The perception of very high costs associated with mAbs has led to the assumption that they play no role in prophylaxis for diseases of poverty. However, improvements in antibody-expression yields and manufacturing processes indicate this is a cost-effective option for providing protection from many types of infection that should be revisited. Recent technology developments also indicate that several months of protection could be achieved with a single dose. Moreover, new methods in B cell sorting now enable the systematic identification of high-quality antibodies from humanized mice, or patients. This Review discusses the potential for passive immunization against schistosomiasis, fungal infections, dengue, and other neglected diseases."
  ],
  "affiliation": [
    "Medicines for Malaria Venture, Geneva, Switzerland."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mycoses"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Dengue"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Schistosomiasis"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Monoclonal"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunization, Passive"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Tropical Medicine"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neglected Diseases"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Development"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antibodies, Monoclonal"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1371/journal.pntd.0007860"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6991954"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6991954?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1371/journal.pntd.0007860"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCompletion": [
    "2020-04-13"
  ],
  "dateOfCreation": [
    "2020-01-31"
  ],
  "firstIndexDate": [
    "2020-02-07"
  ],
  "fullTextReceivedDate": [
    "2020-02-09"
  ],
  "dateOfRevision": [
    "2020-04-13"
  ],
  "electronicPublicationDate": [
    "2020-01-30"
  ],
  "firstPublicationDate": [
    "2020-01-30"
  ]
}